IRWD (STOCKS)
Ironwood Pharmaceuticals, Inc. - Class A
$3.690000
+0.040000 (+1.10%)
Prev close: $3.650000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas A. McCourt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $607.42M
- Employees
- 253
- P/E (TTM)
- 6.11
- P/B (TTM)
- -2.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.24 | $0.24 | -0.0048 | -1.96% |
|
Dec 2025 (Q4)
|
$-0.01 | $0.01 | -0.0202 | -198.04% |
|
Sep 2025 (Q3)
|
$0.24 | $0.10 | +0.1380 | +135.29% |
|
Jun 2025 (Q2)
|
$0.14 | $0.04 | +0.0992 | +243.14% |
Financial Statements
| Revenues | $361.51M |
| Benefits Costs and Expenses | $168.73M |
| Costs And Expenses | $161.33M |
| Nonoperating Income/Loss | -$28.71M |
| Operating Expenses | $161.33M |
| Selling, General, and Administrative Expenses | $70.03M |
| Research and Development | $89.64M |
| Operating Income/Loss | $200.18M |
| Income/Loss From Continuing Operations After Tax | $102.18M |
| Income/Loss From Continuing Operations Before Tax | $177.82M |
| Income Tax Expense/Benefit | $69.29M |
| Net Income/Loss | $102.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $102.18M |
| Net Income/Loss Available To Common Stockholders, Basic | $102.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.64 |
| Diluted Earnings Per Share | $0.60 |
| Basic Average Shares | 487,589,000 |
| Diluted Average Shares | 507,217,000 |
| Assets | $434.57M |
| Current Assets | $332.29M |
| Noncurrent Assets | $102.27M |
| Fixed Assets | $3.17M |
| Other Non-current Assets | $99.11M |
| Liabilities | $651.71M |
| Current Liabilities | $236.31M |
| Accounts Payable | $3.24M |
| Wages | $6.54M |
| Other Current Liabilities | $226.53M |
| Noncurrent Liabilities | $415.40M |
| Equity | -$217.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$217.14M |
| Liabilities And Equity | $434.57M |
| Net Cash Flow From Operating Activities | $112.21M |
| Net Cash Flow From Operating Activities, Continuing | $112.21M |
| Net Cash Flow | $112.42M |
| Net Cash Flow, Continuing | $112.42M |
| Comprehensive Income/Loss | $101.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $101.09M |
| Other Comprehensive Income/Loss | -$3.37M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.09M |